CINECA IRIS Institutional Research Information System

DI STILO, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.904
EU - Europa 2.806
AS - Asia 1.272
AF - Africa 43
SA - Sud America 24
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.070
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.823
CN - Cina 829
IE - Irlanda 411
SE - Svezia 403
IT - Italia 334
DE - Germania 304
UA - Ucraina 286
FR - Francia 257
FI - Finlandia 213
GB - Regno Unito 185
KR - Corea 183
PL - Polonia 138
VN - Vietnam 100
AT - Austria 95
CA - Canada 76
IN - India 53
BE - Belgio 38
JP - Giappone 32
SN - Senegal 28
NL - Olanda 26
RU - Federazione Russa 21
SG - Singapore 19
RO - Romania 18
AU - Australia 14
BR - Brasile 13
HU - Ungheria 12
GR - Grecia 11
HK - Hong Kong 10
TR - Turchia 10
CH - Svizzera 9
CZ - Repubblica Ceca 8
CL - Cile 7
DK - Danimarca 7
ES - Italia 6
IL - Israele 6
IS - Islanda 6
PT - Portogallo 6
TW - Taiwan 6
IR - Iran 5
HR - Croazia 4
MU - Mauritius 4
MX - Messico 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
AM - Armenia 3
EU - Europa 3
ID - Indonesia 3
SC - Seychelles 3
CO - Colombia 2
DZ - Algeria 2
MY - Malesia 2
PK - Pakistan 2
UY - Uruguay 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
BG - Bulgaria 1
BJ - Benin 1
CY - Cipro 1
EG - Egitto 1
IM - Isola di Man 1
IQ - Iraq 1
KE - Kenya 1
LT - Lituania 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
PR - Porto Rico 1
Totale 8.070
Salva come PNG Salva come JPEG
Città #
Chandler 610
Beijing 431
Dublin 408
Ann Arbor 359
Fairfield 239
Ashburn 190
Jacksonville 181
Dearborn 136
Warsaw 134
Houston 130
Villeurbanne 130
Woodbridge 128
Medford 119
Princeton 118
Wilmington 118
Nyköping 116
Seattle 95
Vienna 95
Pisa 92
Dong Ket 81
Cambridge 77
Munich 69
Torino 61
Redwood City 53
Shanghai 49
Fremont 47
Milan 40
Boston 38
Brussels 36
Nanjing 33
Guangzhou 29
Boardman 28
New York 26
Ottawa 26
Toronto 24
Hangzhou 23
Düsseldorf 21
Falls Church 19
Jinan 19
Norwalk 19
Rome 18
Verona 17
Helsinki 16
Lachine 15
Hefei 13
Philadelphia 13
Pune 13
Shenyang 13
Washington 13
Zhengzhou 12
Amsterdam 11
San Diego 11
Phoenix 10
Singapore 10
Wuhan 9
Xian 9
Chengdu 8
Kunming 8
Pittsburgh 8
San Jose 8
Seoul 8
Silver Spring 8
Monmouth Junction 7
Fuzhou 6
Harbin 6
Kharkiv 6
Nanchang 6
Budapest 5
Changsha 5
Copenhagen 5
Mountain View 5
Qingdao 5
Rivoli 5
Tokyo 5
Almada 4
Central 4
Chongqing 4
Cluj-napoca 4
Delhi 4
Dresden 4
Hanoi 4
Miami 4
Nagoya 4
Nuremberg 4
Santa Clara 4
Seongnam 4
Tianjin 4
Toledo 4
Avellino 3
Baotou 3
Biatorbágy 3
Bologna 3
Buffalo 3
Chambonas 3
Chicago 3
Cluj 3
Dallas 3
Hamilton 3
Haridwar 3
Hebei 3
Totale 5.056
Salva come PNG Salva come JPEG
Nome #
Electrophilic Warhead-Based Design of Compounds Preventing NLRP3 Inflammasome-Dependent Pyroptosis 588
Stable Oxidative Cytosine Modifications Accumulate in Cardiac Mesenchymal Cells from Type2 Diabetes Patients: Rescue by alpha Ketoglutarate and TET-TDG Functional Reactivation 387
1,1-Dinitroethyl substituted furoxans : a new class of vasodilators and inhibitors of platelet aggregation 341
Validation of a GC/MS method for the detection of two quinoline-derived selective androgen receptor modulators in doping control analysis 187
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins 186
New nitric oxide or hydrogen sulfide releasing aspirins 164
Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants 155
Effects of Nitric Oxide Donor Antioxidants Containing the Phenol Vitamin E Substructure and a Furoxan Moiety on Ischemia/Riperfusion Injury 146
Nitrooxymethyl Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization 139
Nitrooxymethyl-Substituted Analogues of Rofecoxib: Synthesis and Pharmacological Characterization 134
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs) 125
A LIPOPHILIC NITRIC OXIDE-DONOR AND A LIPOPHILIC ANTIOXIDANT COMPOUND PROTECT RAT HEART AGAINST ISCHEMIA-REPERFUSION INJURY IF GIVEN AS HYBRID MOLECULE BUT NOT AS A MIXTURE. 125
Microwave-assisted synthesis of N-heterocycles in medicinal chemistry 123
Multitarget Drugs: Synthesis and Preliminary Pharmacological Characterization of Zileuton Analogues Endowed with Dual 5-LO Inhibitor and NO-Dependent Activities 120
A new class of NO-donor H3-Antagonists 117
Amphiphilic NO-Donor Antioxidants 117
Multitarget Drugs: Focus on the NO-donor hybrid drugs 114
Synthesis of Some Novel Organic Nitrates and Comparative in Vitro Study of Their Vasodilator Profile 108
Design, Synthesis and Pharmacological Evaluation of Anti-Pyroptotic Compounds Acting on NLRP3 Inflammasome Signaling Pathway: a New Start for Anti-Inflammatory Drugs? 108
New organic nitrate-containing benzyloxy isonipecotanilide derivatives with vasodilatory and anti-platelet activity 107
NO-donors: focus on furoxan derivatives 105
Use of Nitric Oxide Releasing Furoxan System in the Design of "Hybrids": Substitution of Furoxan Moieties for the Furan Ring in Prazosin 104
Cardiac Epi-Metabolic Signature Revealed by Integrated Omics Approach in Diabetic Patients: Rescue by Active DNA Demethylation via TET-TDG Complex Reactivation 104
SAR STUDIES ON H2 ANTAGONISTS CONTAINING ALKYLAMINO SUBSTITUTED 1,2,5-THIADIAZOLE 1-OXIDE MOIETIES 102
NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties 101
Non-conventional extractions and antioxidant properties evaluation of microalga Spirulina maxima 100
Applicazione di una tecnica innovativa alle analisi per i controlli antidoping: determinazione di diuretici mediante fast-GC/MS 99
New potential uroselective NO-donor a1-antagonists 97
[3-(1H-Imidazol-4-yl)propyl)guanidines Containing Furoxan Moieties: A New Class of H3-Antagonists Endowed with NO-Donor Properties 94
ALPHA(1)-ADRENOCEPTOR BLOCKING ACTIVITY OF SOME RING-OPEN ANALOGS OF PRAZOSIN 93
Synthesis and Structure of a Trimer of the Furoxan System with High Vasodilator and Platelet Antiaggregatory Activity 93
Anti-Helicobacter pylori Agents Endowed with H2-antagonist Properties 89
Characterisation of Furoxancarbonitriles as a New Class of Vasodilators 89
Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives 86
Use of the Morita-Baylis-Hillman reaction in the design of compounds inhibiting NLRP3 inflammasome signaling pathways 86
Furoxan derivatives as NO-donors 82
Studies on New Basic NO-Donor 1,4-Dihydropyridines 80
Novel Organic Nitrate Esters 80
Searching for Balanced Hybrid NO-Donor 1,4-Dihydropyridines with Basic Properties 80
CC1000: a new cardioprotective agent against ischemia/reperfusion injuries 80
Targeting NLRP3 inflammasome regulatory mechanisms: design of anti-pyroptotic compounds for autoinflammatory diseases 80
Pharmacochemistry of the Furoxan Ring : Recent Developments 79
WATER SOLUBLE FUROXAN DERIVATIVES AS NO PRODRUGS 77
Recent advances in the cyclization of N-heterocycles: the role of enabling techniques 77
Synthesis and structural characterization of the trimeric furoxan (equals furazan 2-oxide) system, a new potent vasodilating moiety 75
Cytotoxic Activity of a Series of Heteroaryl-ONN-azoxysulphones and Arylsulphonylhydrazones 70
Furoxans as Nitric Oxide Donors. 4-Phenyl-3-furoxancarbonitrile: Thiol-Mediated Nitric Oxide Release and Biological Evaluation 69
New 1,4-Dihydropyridines Conjugated to Furoxanyl Moieties, endowed With both NO-like and Ca2+ Channel Antagonist Vasodilator Activities 69
Cyano-NNO-azoxy Analogs of Nifedipine 69
Synthesis and preliminary evaluation of model compounds targeting the NLRP3 inflammasome pathways 69
Synthesis and H2-Antagonist Properties of some 1,2,5-Thiadiazole-1-oxide Derivatives 66
Mass spectrometry of quinolinone-derived selective androgen receptor modulators (SARMs) 66
Combined protective effect of nitric oxide donor and antioxidants in the rat heart 64
Use of Nitric Oxide Releasing Furoxan System in the Design of Hybrids With mixed NO-like Vasodilator Activity and *1-Antagonistic Properties 63
Effetto del post-condizionamento farmacologico sui danni da ischemia e riperfusione 63
Identification of Small Synthetic Anti-Pyroptotic Compounds 62
L'effetto protettivo di un ibrido con proprietà antiossidante e NO donatrice contro i danni da ischemia e riperfusione nel cuore isolato di ratto 59
Furan and Thiophene analogues of omeprazole 59
"Enabling Technologies": a Step ahead in the Synthesis of Nitrogen-Containing Heterocycles 58
Synthesis and Pharmacological Evaluation of Novel H3 Antagonists Endowed with NO-Donor Properties 56
Studies on Agents with Mixed NO-Dependent and Calcium Channel Antagonistic Vasodilating Activities. 56
Low concentrations of an nitric oxide-donor combined with a liposoluble antioxidant compound enhance protection against reperfusion injury in isolated rat hearts 56
Unsymmetrically Substituted Furoxans. Part 11. Methylfuroxancarbaldehydes 56
The Cyano-NNO-Azoxy Function in the Design of an Irreversible Label for a1 Adrenoreceptors 55
In Vitro Cytotoxic Activity of Aryl and Heteroaryl-ONN-Azoxycyanides 53
NO donor - melatonins: a new class of potential antiatherosclerosis agents 52
The Furoxan System as a Useful Tool to Balancing "Hybrids" with mixed alfa1-Antagonist and NO-Like Vasodilator Activities 51
Vasodilating profile of a new series of analogues of GTN 50
New NO-donor Bisphosphonates 48
Nitric oxide and antioxidant activity in the protection of the heart ischemia/reperfusion injury 48
Synthesis, chiral HPLC resolution and configuration assignment of 1-phenylglyceryl trinitrate stereomers 47
New 1,4-dihydropyridines endowed with NO-donor and calcium channel agonist properties 47
NO donor and biological properties of different benzofuroxans. 45
Tolerance profile of new organic nitrates with antioxidant properties 45
New Uroselective NO-Donor a1-antagonists 43
Synthesis and vasodilating properties of N-alkylamide derivatives of 4-amino-3-furoxancarboxylic acid and related azo derivatives 43
Pyrazole analogues of prazosin 43
Post-conditioning with NO-donors and antioxidant compounds 43
Myocardial protection in the rat heart and role of weak and strong NO-release from a hybrid molecule containing an antioxidant substructure 43
Validation of a GC/MS method for the detection of two quinolinone-derived selective androgen receptor modulators in doping control analysis 43
STUDIES ON AGENTS WITH MIXED NO-DEPENDENT VASODILATING AND β-BLOCKING ACTIVITIES 42
In vitro and in vivo vasodilating activity of nitroso derivatives gem -substituted with electron-withdrawing groups. 41
Fast gaschromatographic/mass spectrometric determination of diuretics and masking agents in human urine. Development and validation of a productive screening protocol for antidoping analysis 41
Nitric oxide release by an edavarone derivative containing NOdonor furoxan moiety contributes to the resolution of renal injury after ischemia/reperfusion in the rat 41
High-speed gas chromatography in doping control: Fast-GC and fast-GC/MS determination of beta-adrenoceptor ligands and diuretics 41
Studies of the potential genotoxic effects of furoxans: the case of CAS 1609 and of the water soluble analogue of CHF 2363 41
Non-imidazole histamine NO-donor H3-antagonists 40
Physicochemical profile and in vitro permeation behavior of a new class of non-steroidal anti-inflammatory drug candidates 39
The Furoxan System: Design of Selective Nitric Oxide (NO) Donor Inhibitors of COX-2 Endowed with Anti-Aggregatory and Vasodilating Activities 38
Nicorandil analogues containing NO-donor furoxans and related furazans 37
Michael addition of Grignard reagents to tetraethyl ethenylidenebisphosphonate 36
High-speed gas-chromatography in doping control analyses: fast GC, ultrafast GC and fast GC/MS determination of Doping Substances 34
Nitric oxide (NO) donor beta(2)-agonists:furoxan derivatives containing the fenoterol moiety and related furazans 33
Fast gas-chromatography coupled mass spectrometry: rapid determination of diuretics in doping analysis 30
LIPOPHILIC NO-DONOR AND LIPOPHILIC ANTIOXIDANT COMPOUND IN MYOCARDIAL PROTECTION AGAINST ISCHEMIA-REPERFUSION INJURY 29
Potential Histamine H2-receptor Antagonists: Synthesis and Pharmacological Activity of Derivatives Containing Acylaminofurazan moieties 29
Simultaneous ultrasound-assisted water extraction and β-cyclodextrin encapsulation of polyphenols from Mangifera indica stem bark in counteracting TNFα-induced endothelial dysfunction 29
Totale 8.373
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.402
article - articoli 0
book - libri 0
conference - conferenze 5.220
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.622
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019318 0 0 0 0 0 0 0 0 0 0 231 87
2019/20201.226 50 47 99 120 94 182 149 86 132 136 72 59
2020/2021894 99 59 74 48 62 56 55 37 156 62 47 139
2021/20221.307 40 40 63 85 98 16 142 83 43 164 267 266
2022/20231.675 207 167 60 168 135 389 211 98 125 31 50 34
2023/2024514 76 90 47 32 60 106 20 37 4 27 15 0
Totale 8.373